Amphastar Pharmaceuticals Total Current Assets 2012-2024 | AMPH
Amphastar Pharmaceuticals total current assets from 2012 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Amphastar Pharmaceuticals Annual Total Current Assets
(Millions of US $) |
| 2023 |
$490 |
| 2022 |
$378 |
| 2021 |
$318 |
| 2020 |
$280 |
| 2019 |
$255 |
| 2018 |
$220 |
| 2017 |
$188 |
| 2016 |
$184 |
| 2015 |
$176 |
| 2014 |
$198 |
| 2013 |
$173 |
| 2012 |
$166 |
| 2011 |
$ |
| 2009 |
$44 |
Amphastar Pharmaceuticals Quarterly Total Current Assets
(Millions of US $) |
| 2024-06-30 |
$483 |
| 2024-03-31 |
$555 |
| 2023-12-31 |
$490 |
| 2023-09-30 |
$543 |
| 2023-06-30 |
$385 |
| 2023-03-31 |
$408 |
| 2022-12-31 |
$378 |
| 2022-09-30 |
$384 |
| 2022-06-30 |
$377 |
| 2022-03-31 |
$364 |
| 2021-12-31 |
$318 |
| 2021-09-30 |
$304 |
| 2021-06-30 |
$311 |
| 2021-03-31 |
$300 |
| 2020-12-31 |
$280 |
| 2020-09-30 |
$277 |
| 2020-06-30 |
$267 |
| 2020-03-31 |
$247 |
| 2019-12-31 |
$255 |
| 2019-09-30 |
$269 |
| 2019-06-30 |
$284 |
| 2019-03-31 |
$230 |
| 2018-12-31 |
$220 |
| 2018-09-30 |
$195 |
| 2018-06-30 |
$170 |
| 2018-03-31 |
$174 |
| 2017-12-31 |
$188 |
| 2017-09-30 |
$176 |
| 2017-06-30 |
$194 |
| 2017-03-31 |
$191 |
| 2016-12-31 |
$184 |
| 2016-09-30 |
$190 |
| 2016-06-30 |
$181 |
| 2016-03-31 |
$173 |
| 2015-12-31 |
$176 |
| 2015-09-30 |
$199 |
| 2015-06-30 |
$204 |
| 2015-03-31 |
$203 |
| 2014-12-31 |
$198 |
| 2014-09-30 |
$215 |
| 2014-06-30 |
$214 |
| 2014-03-31 |
$177 |
| 2013-12-31 |
$173 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$166 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.438B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
